DIN 02535696 — CALQUENCE 100 MG
CALQUENCE is a tablet of Acalabrutinib marketed by ASTRAZENECA CANADA INC. The full Acalabrutinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02535696
- Brand name
- CALQUENCE
- Active ingredient
- Acalabrutinib
- Strength
- 100 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Bruton's tyrosine kinase (BTK) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Acalabrutinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02491788 | CALQUENCE | 100 MG | CAPSULE | ASTRAZENECA CANADA INC | DORMANT |